866-997-4948(US-Canada Toll Free)

Global Anti-Obesity Therapeutics Market Research Report 2018

Published By :

QYResearch

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 90 Pages

This report studies the global Anti-Obesity Therapeutics market status and forecast, categorizes the global Anti-Obesity Therapeutics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.
Geographically, North America captures the largest market share on account of increasing obese population. As per the historical trends, more than one-third of the U.S. population is obese. However, Asia Pacific is anticipated to grow at the fastest rate due to increasing demand for the drugs and awareness about the risk associated with obesity. According to WHO, 13.0% of the population were obese in 2014. In developing countries the rate of childhood obesity is increasing and has been 30.0% higher than that of developed countries.
The global Anti-Obesity Therapeutics market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report
Bristol-Myers Squibb
Eisai Company
FlaxoSithKline plc.
Novo Nordisk
Alizyme
BoehringerIngelheim GmbH
Pfizer
Takeda Pharmaceutical
Rhythm Pharmaceuticals
Shionogi USA
Vivus
Zafgen
Norgine Pharmaceuticals Ltd.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Centrally Acting Anti-obesity Drugs
Peripherally Acting Anti-obesity Drugs
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospital Use
Clinic Use
Household
Other

The study objectives of this report are:
To analyze and study the global Anti-Obesity Therapeutics sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Anti-Obesity Therapeutics manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Anti-Obesity Therapeutics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Anti-Obesity Therapeutics Manufacturers
Anti-Obesity Therapeutics Distributors/Traders/Wholesalers
Anti-Obesity Therapeutics Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Anti-Obesity Therapeutics market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents

Global Anti-Obesity Therapeutics Market Research Report 2018
1 Anti-Obesity Therapeutics Market Overview
1.1 Product Overview and Scope of Anti-Obesity Therapeutics
1.2 Anti-Obesity Therapeutics Segment by Type (Product Category)
1.2.1 Global Anti-Obesity Therapeutics Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Anti-Obesity Therapeutics Production Market Share by Type (Product Category) in 2017
1.2.3 Centrally Acting Anti-obesity Drugs
1.2.4 Peripherally Acting Anti-obesity Drugs
1.3 Global Anti-Obesity Therapeutics Segment by Application
1.3.1 Anti-Obesity Therapeutics Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Global Anti-Obesity Therapeutics Market by Region (2013-2025)
1.4.1 Global Anti-Obesity Therapeutics Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Anti-Obesity Therapeutics (2013-2025)
1.5.1 Global Anti-Obesity Therapeutics Revenue Status and Outlook (2013-2025)
1.5.2 Global Anti-Obesity Therapeutics Capacity, Production Status and Outlook (2013-2025)

2 Global Anti-Obesity Therapeutics Market Competition by Manufacturers
2.1 Global Anti-Obesity Therapeutics Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Anti-Obesity Therapeutics Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Anti-Obesity Therapeutics Production and Share by Manufacturers (2013-2018)
2.2 Global Anti-Obesity Therapeutics Revenue and Share by Manufacturers (2013-2018)
2.3 Global Anti-Obesity Therapeutics Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Anti-Obesity Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
2.5 Anti-Obesity Therapeutics Market Competitive Situation and Trends
2.5.1 Anti-Obesity Therapeutics Market Concentration Rate
2.5.2 Anti-Obesity Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Anti-Obesity Therapeutics Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Anti-Obesity Therapeutics Capacity and Market Share by Region (2013-2018)
3.2 Global Anti-Obesity Therapeutics Production and Market Share by Region (2013-2018)
3.3 Global Anti-Obesity Therapeutics Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Anti-Obesity Therapeutics Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Anti-Obesity Therapeutics Consumption by Region (2013-2018)
4.2 North America Anti-Obesity Therapeutics Production, Consumption, Export, Import (2013-2018)
4.3 Europe Anti-Obesity Therapeutics Production, Consumption, Export, Import (2013-2018)
4.4 China Anti-Obesity Therapeutics Production, Consumption, Export, Import (2013-2018)
4.5 Japan Anti-Obesity Therapeutics Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Anti-Obesity Therapeutics Production, Consumption, Export, Import (2013-2018)
4.7 India Anti-Obesity Therapeutics Production, Consumption, Export, Import (2013-2018)

5 Global Anti-Obesity Therapeutics Production, Revenue (Value), Price Trend by Type
5.1 Global Anti-Obesity Therapeutics Production and Market Share by Type (2013-2018)
5.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Type (2013-2018)
5.3 Global Anti-Obesity Therapeutics Price by Type (2013-2018)
5.4 Global Anti-Obesity Therapeutics Production Growth by Type (2013-2018)

6 Global Anti-Obesity Therapeutics Market Analysis by Application
6.1 Global Anti-Obesity Therapeutics Consumption and Market Share by Application (2013-2018)
6.2 Global Anti-Obesity Therapeutics Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Anti-Obesity Therapeutics Manufacturers Profiles/Analysis
7.1 Bristol-Myers Squibb
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Anti-Obesity Therapeutics Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Bristol-Myers Squibb Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Eisai Company
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Anti-Obesity Therapeutics Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Eisai Company Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 FlaxoSithKline plc.
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Anti-Obesity Therapeutics Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 FlaxoSithKline plc. Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Novo Nordisk
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Anti-Obesity Therapeutics Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Novo Nordisk Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Alizyme
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Anti-Obesity Therapeutics Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Alizyme Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 BoehringerIngelheim GmbH
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Anti-Obesity Therapeutics Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Pfizer
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Anti-Obesity Therapeutics Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Pfizer Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Takeda Pharmaceutical
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Anti-Obesity Therapeutics Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Takeda Pharmaceutical Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Rhythm Pharmaceuticals
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Anti-Obesity Therapeutics Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Shionogi USA
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Anti-Obesity Therapeutics Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Shionogi USA Anti-Obesity Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
7.10.4 Main Business/Business Overview
7.11 Vivus
7.12 Zafgen
7.13 Norgine Pharmaceuticals Ltd.

8 Anti-Obesity Therapeutics Manufacturing Cost Analysis
8.1 Anti-Obesity Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Anti-Obesity Therapeutics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Anti-Obesity Therapeutics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Anti-Obesity Therapeutics Major Manufacturers in 2017
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Anti-Obesity Therapeutics Market Forecast (2018-2025)
12.1 Global Anti-Obesity Therapeutics Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Anti-Obesity Therapeutics Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Anti-Obesity Therapeutics Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Anti-Obesity Therapeutics Price and Trend Forecast (2018-2025)
12.2 Global Anti-Obesity Therapeutics Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Anti-Obesity Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Anti-Obesity Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Anti-Obesity Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Anti-Obesity Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Anti-Obesity Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Anti-Obesity Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Anti-Obesity Therapeutics Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Anti-Obesity Therapeutics Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Anti-Obesity Therapeutics
Figure Global Anti-Obesity Therapeutics Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Anti-Obesity Therapeutics Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Centrally Acting Anti-obesity Drugs
Table Major Manufacturers of Centrally Acting Anti-obesity Drugs
Figure Product Picture of Peripherally Acting Anti-obesity Drugs
Table Major Manufacturers of Peripherally Acting Anti-obesity Drugs
Figure Global Anti-Obesity Therapeutics Consumption (K Units) by Applications (2013-2025)
Figure Global Anti-Obesity Therapeutics Consumption Market Share by Applications in 2017
Figure Hospital Use Examples
Table Key Downstream Customer in Hospital Use
Figure Clinic Use Examples
Table Key Downstream Customer in Clinic Use
Figure Household Examples
Table Key Downstream Customer in Household
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Anti-Obesity Therapeutics Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
Figure North America Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Anti-Obesity Therapeutics Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Anti-Obesity Therapeutics Capacity, Production (K Units) Status and Outlook (2013-2025)
Figure Global Anti-Obesity Therapeutics Major Players Product Capacity (K Units) (2013-2018)
Table Global Anti-Obesity Therapeutics Capacity (K Units) of Key Manufacturers (2013-2018)
Table Global Anti-Obesity Therapeutics Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Anti-Obesity Therapeutics Capacity (K Units) of Key Manufacturers in 2017
Figure Global Anti-Obesity Therapeutics Capacity (K Units) of Key Manufacturers in 2018
Figure Global Anti-Obesity Therapeutics Major Players Product Production (K Units) (2013-2018)
Table Global Anti-Obesity Therapeutics Production (K Units) of Key Manufacturers (2013-2018)
Table Global Anti-Obesity Therapeutics Production Share by Manufacturers (2013-2018)
Figure 2017 Anti-Obesity Therapeutics Production Share by Manufacturers
Figure 2017 Anti-Obesity Therapeutics Production Share by Manufacturers
Figure Global Anti-Obesity Therapeutics Major Players Product Revenue (Million USD) (2013-2018)
Table Global Anti-Obesity Therapeutics Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Anti-Obesity Therapeutics Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Anti-Obesity Therapeutics Revenue Share by Manufacturers
Table 2018 Global Anti-Obesity Therapeutics Revenue Share by Manufacturers
Table Global Market Anti-Obesity Therapeutics Average Price (USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Anti-Obesity Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Anti-Obesity Therapeutics Manufacturing Base Distribution and Sales Area
Table Manufacturers Anti-Obesity Therapeutics Product Category
Figure Anti-Obesity Therapeutics Market Share of Top 3 Manufacturers
Figure Anti-Obesity Therapeutics Market Share of Top 5 Manufacturers
Table Global Anti-Obesity Therapeutics Capacity (K Units) by Region (2013-2018)
Figure Global Anti-Obesity Therapeutics Capacity Market Share by Region (2013-2018)
Figure Global Anti-Obesity Therapeutics Capacity Market Share by Region (2013-2018)
Figure 2017 Global Anti-Obesity Therapeutics Capacity Market Share by Region
Table Global Anti-Obesity Therapeutics Production by Region (2013-2018)
Figure Global Anti-Obesity Therapeutics Production (K Units) by Region (2013-2018)
Figure Global Anti-Obesity Therapeutics Production Market Share by Region (2013-2018)
Figure 2017 Global Anti-Obesity Therapeutics Production Market Share by Region
Table Global Anti-Obesity Therapeutics Revenue (Million USD) by Region (2013-2018)
Table Global Anti-Obesity Therapeutics Revenue Market Share by Region (2013-2018)
Figure Global Anti-Obesity Therapeutics Revenue Market Share by Region (2013-2018)
Table 2017 Global Anti-Obesity Therapeutics Revenue Market Share by Region
Figure Global Anti-Obesity Therapeutics Capacity, Production (K Units) and Growth Rate (2013-2018)
Table Global Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Europe Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Anti-Obesity Therapeutics Consumption (K Units) Market by Region (2013-2018)
Table Global Anti-Obesity Therapeutics Consumption Market Share by Region (2013-2018)
Figure Global Anti-Obesity Therapeutics Consumption Market Share by Region (2013-2018)
Figure 2017 Global Anti-Obesity Therapeutics Consumption (K Units) Market Share by Region
Table North America Anti-Obesity Therapeutics Production, Consumption, Import & Export (K Units) (2013-2018)
Table Europe Anti-Obesity Therapeutics Production, Consumption, Import & Export (K Units) (2013-2018)
Table China Anti-Obesity Therapeutics Production, Consumption, Import & Export (K Units) (2013-2018)
Table Japan Anti-Obesity Therapeutics Production, Consumption, Import & Export (K Units) (2013-2018)
Table Southeast Asia Anti-Obesity Therapeutics Production, Consumption, Import & Export (K Units) (2013-2018)
Table India Anti-Obesity Therapeutics Production, Consumption, Import & Export (K Units) (2013-2018)
Table Global Anti-Obesity Therapeutics Production (K Units) by Type (2013-2018)
Table Global Anti-Obesity Therapeutics Production Share by Type (2013-2018)
Figure Production Market Share of Anti-Obesity Therapeutics by Type (2013-2018)
Figure 2017 Production Market Share of Anti-Obesity Therapeutics by Type
Table Global Anti-Obesity Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Anti-Obesity Therapeutics Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Anti-Obesity Therapeutics by Type (2013-2018)
Figure 2017 Revenue Market Share of Anti-Obesity Therapeutics by Type
Table Global Anti-Obesity Therapeutics Price (USD/Unit) by Type (2013-2018)
Figure Global Anti-Obesity Therapeutics Production Growth by Type (2013-2018)
Table Global Anti-Obesity Therapeutics Consumption (K Units) by Application (2013-2018)
Table Global Anti-Obesity Therapeutics Consumption Market Share by Application (2013-2018)
Figure Global Anti-Obesity Therapeutics Consumption Market Share by Applications (2013-2018)
Figure Global Anti-Obesity Therapeutics Consumption Market Share by Application in 2017
Table Global Anti-Obesity Therapeutics Consumption Growth Rate by Application (2013-2018)
Figure Global Anti-Obesity Therapeutics Consumption Growth Rate by Application (2013-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (Bristol-Myers Squibb) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Anti-Obesity Therapeutics Production Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Anti-Obesity Therapeutics Production Market Share (2013-2018)
Figure Bristol-Myers Squibb Anti-Obesity Therapeutics Revenue Market Share (2013-2018)
Table Eisai Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Company Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eisai Company Anti-Obesity Therapeutics Production Growth Rate (2013-2018)
Figure Eisai Company Anti-Obesity Therapeutics Production Market Share (2013-2018)
Figure Eisai Company Anti-Obesity Therapeutics Revenue Market Share (2013-2018)
Table FlaxoSithKline plc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table FlaxoSithKline plc. Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure FlaxoSithKline plc. Anti-Obesity Therapeutics Production Growth Rate (2013-2018)
Figure FlaxoSithKline plc. Anti-Obesity Therapeutics Production Market Share (2013-2018)
Figure FlaxoSithKline plc. Anti-Obesity Therapeutics Revenue Market Share (2013-2018)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novo Nordisk Anti-Obesity Therapeutics Production Growth Rate (2013-2018)
Figure Novo Nordisk Anti-Obesity Therapeutics Production Market Share (2013-2018)
Figure Novo Nordisk Anti-Obesity Therapeutics Revenue Market Share (2013-2018)
Table Alizyme Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alizyme Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Alizyme Anti-Obesity Therapeutics Production Growth Rate (2013-2018)
Figure Alizyme Anti-Obesity Therapeutics Production Market Share (2013-2018)
Figure Alizyme Anti-Obesity Therapeutics Revenue Market Share (2013-2018)
Table BoehringerIngelheim GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BoehringerIngelheim GmbH Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure BoehringerIngelheim GmbH Anti-Obesity Therapeutics Production Growth Rate (2013-2018)
Figure BoehringerIngelheim GmbH Anti-Obesity Therapeutics Production Market Share (2013-2018)
Figure BoehringerIngelheim GmbH Anti-Obesity Therapeutics Revenue Market Share (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Anti-Obesity Therapeutics Production Growth Rate (2013-2018)
Figure Pfizer Anti-Obesity Therapeutics Production Market Share (2013-2018)
Figure Pfizer Anti-Obesity Therapeutics Revenue Market Share (2013-2018)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceutical Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Takeda Pharmaceutical Anti-Obesity Therapeutics Production Growth Rate (2013-2018)
Figure Takeda Pharmaceutical Anti-Obesity Therapeutics Production Market Share (2013-2018)
Figure Takeda Pharmaceutical Anti-Obesity Therapeutics Revenue Market Share (2013-2018)
Table Rhythm Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Rhythm Pharmaceuticals Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Rhythm Pharmaceuticals Anti-Obesity Therapeutics Production Growth Rate (2013-2018)
Figure Rhythm Pharmaceuticals Anti-Obesity Therapeutics Production Market Share (2013-2018)
Figure Rhythm Pharmaceuticals Anti-Obesity Therapeutics Revenue Market Share (2013-2018)
Table Shionogi USA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shionogi USA Anti-Obesity Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shionogi USA Anti-Obesity Therapeutics Production Growth Rate (2013-2018)
Figure Shionogi USA Anti-Obesity Therapeutics Production Market Share (2013-2018)
Figure Shionogi USA Anti-Obesity Therapeutics Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Obesity Therapeutics
Figure Manufacturing Process Analysis of Anti-Obesity Therapeutics
Figure Anti-Obesity Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Anti-Obesity Therapeutics Major Manufacturers in 2017
Table Major Buyers of Anti-Obesity Therapeutics
Table Distributors/Traders List
Figure Global Anti-Obesity Therapeutics Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Anti-Obesity Therapeutics Price (Million USD) and Trend Forecast (2018-2025)
Table Global Anti-Obesity Therapeutics Production (K Units) Forecast by Region (2018-2025)
Figure Global Anti-Obesity Therapeutics Production Market Share Forecast by Region (2018-2025)
Table Global Anti-Obesity Therapeutics Consumption (K Units) Forecast by Region (2018-2025)
Figure Global Anti-Obesity Therapeutics Consumption Market Share Forecast by Region (2018-2025)
Figure North America Anti-Obesity Therapeutics Production (K Units) and Growth Rate Forecast (2018-2025)
Figure North America Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Anti-Obesity Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Europe Anti-Obesity Therapeutics Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Anti-Obesity Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure China Anti-Obesity Therapeutics Production (K Units) and Growth Rate Forecast (2018-2025)
Figure China Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Anti-Obesity Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Japan Anti-Obesity Therapeutics Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Anti-Obesity Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Southeast Asia Anti-Obesity Therapeutics Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Anti-Obesity Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure India Anti-Obesity Therapeutics Production (K Units) and Growth Rate Forecast (2018-2025)
Figure India Anti-Obesity Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Anti-Obesity Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Table Global Anti-Obesity Therapeutics Production (K Units) Forecast by Type (2018-2025)
Figure Global Anti-Obesity Therapeutics Production (K Units) Forecast by Type (2018-2025)
Table Global Anti-Obesity Therapeutics Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Anti-Obesity Therapeutics Revenue Market Share Forecast by Type (2018-2025)
Table Global Anti-Obesity Therapeutics Price Forecast by Type (2018-2025)
Table Global Anti-Obesity Therapeutics Consumption (K Units) Forecast by Application (2018-2025)
Figure Global Anti-Obesity Therapeutics Consumption (K Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *